A Study of AMG 820 in Subjects With Advanced Solid Tumors
NCT01444404
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
25
Enrollment
INDUSTRY
Sponsor class
Conditions
Advanced Malignancy
Advanced Solid Tumors
Cancer
Oncology
Oncology Patients
Tumors
Interventions
DRUG:
AMG 820
Sponsor
AmMax Bio, Inc.